Clinical Trial Update: MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 clinical trial from PGIMER Chandigarh evaluating dapagliflozin for metabolic dysfunction-associated steatotic liver disease in individuals with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Hepatic Steato-Fibrosis, Non-Alcoholic Fatty Liver Disease | EARLY_Phase 1 | Status: NOT_YET_RECRUITING